Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-? present in serum from patients with systemic lupus erythematosus
about
Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory DermatosesRapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodiesMechanisms of action of intravenous immunoglobulins.Gene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapy.IVIG regulates the survival of human but not mouse neutrophils.Antibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeutics.The use of i.v. IG therapy in dermatology.Natural antibodies sustain differentiation and maturation of human dendritic cells.Accessing the human repertoire for broadly neutralizing HIV antibodies.Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patientsIntravenous immunoglobulin therapy in rheumatic diseases.The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies.Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute.Review: intravenous immunoglobulin and B cells: when the product regulates the producer.IVIG-mediated effector functions in autoimmune and inflammatory diseases.Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice.Cytokine-induced monocyte characteristics in SLEDose-related regulatory effect of intravenous immunoglobulin on dendritic cells-mediated immune response.Intravenous immunoglobulin skews macrophages to an anti-inflammatory, IL-10-producing activation state.Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG).Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patientsInterferon-α Inhibition by Intravenous Immunoglobulin Is Independent of Modulation of the Plasmacytoid Dendritic Cell Population in the Circulation: Comment on the Article by Wiedeman et alIntravenous Immunoglobulins in Autoimmune and Inflammatory Diseases: A Mechanistic PerspectiveNatural autoantibodies: immune homeostasis and therapeutic intervention
P2860
Q26765226-89EFE0DA-3AF3-43EE-A066-04A5DF03AA41Q26864907-CE5E984A-EEB3-4365-AF89-B252AA3654DFQ33389428-66191C5E-B10A-4724-95C5-95DD4E34393DQ33618367-F46E0A0B-1E8B-4261-82D8-70AC24D832F4Q33683531-CCE8D037-3195-4260-A435-00E471A52002Q36755847-38499F58-43E1-4448-8B14-8C60959E6D24Q36986054-AF2253D1-D997-4B1C-B02F-25FDA518004CQ37557503-4D14F21A-5B2D-4938-BA98-CA76C649FECBQ37694976-2060BDBE-B69E-4DC9-B535-79A7F07ED80BQ37732919-9E53319D-614D-4B87-8752-36BCD2E5ABDAQ37873722-1F4BB31A-22CF-49D9-A008-5D6A7C8D6664Q38117686-26639A3D-95D9-47BF-B6B6-3D67689F7325Q38133405-5E30B6B6-CC29-4FDC-B9FA-62E11FA81F7AQ38258905-C65F6135-6D73-4B99-B568-F5939B31BC02Q38699812-526F67B7-9AA7-43AB-B0BE-031DADF86BBDQ38754861-69BCDFB9-D762-4F27-A4D8-183BD13E9885Q38820288-19FBD35F-C06F-4A3A-A88C-B2477F443DDCQ40263968-3ED0A34A-1ACF-4CA1-946B-41244586EB95Q42141284-7B0D89C1-C7FD-4205-A3A3-C695CF104289Q42251007-A30E139C-5752-47DD-9496-9A8AF7E95CF9Q44680490-FB91610E-3AF3-4E4C-9E1B-10D64DBD2367Q50711133-A4643B79-EF6F-475B-8BE6-731A24FE2B24Q58861212-04121846-E7B2-4106-8EE7-818511FE4CBBQ58861214-82E67675-EA38-452F-8494-50ACB3522B82Q58864646-5929E2F6-7ABB-4DCC-8348-FCB894DA00CBQ58864672-BE32A32A-38FE-490E-95EF-4B5F923F1857
P2860
Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-? present in serum from patients with systemic lupus erythematosus
description
scientific article published on 01 December 2003
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2003
@uk
name
Intravenous immunoglobulin abr ...... h systemic lupus erythematosus
@en
Intravenous immunoglobulin abr ...... h systemic lupus erythematosus
@nl
type
label
Intravenous immunoglobulin abr ...... h systemic lupus erythematosus
@en
Intravenous immunoglobulin abr ...... h systemic lupus erythematosus
@nl
prefLabel
Intravenous immunoglobulin abr ...... h systemic lupus erythematosus
@en
Intravenous immunoglobulin abr ...... h systemic lupus erythematosus
@nl
P2093
P921
P356
P1476
Intravenous immunoglobulin abr ...... h systemic lupus erythematosus
@en
P2093
Bernard Weill
Luc Mouthon
Michel D Kazatchkine
Sandrine Delignat
Srini V Kaveri
P304
P356
10.1002/ART.11346
P577
2003-12-01T00:00:00Z